Crossref
journal-article
Elsevier BV
Kidney International (78)
References
58
Referenced
114
{'key': '10.1038/ki.1995.205_bb0010', 'first-page': '647', 'article-title': 'In vitro and in vivo pharmacologic activities of antisense oligonucleotides', 'volume': '6', 'author': 'Mirabelli', 'year': '1991', 'journal-title': 'Anticancer Drug Des'}
/ Anticancer Drug Des / In vitro and in vivo pharmacologic activities of antisense oligonucleotides by Mirabelli (1991)10.1096/fasebj.7.6.7682523
/ FASEB J / Progress toward oligonucleotide therapeutics: Pharmacodynamic properties by Crooke (1993)10.1093/nar/19.5.1113
/ Nucl Acids Res / Inhibition of translation initiation by antisense oligonucleotides via an RNase-H independent mechanism by Boiziau (1991)10.1016/S0021-9258(19)49937-7
/ J Biol Chem / Modulation of eucaryotic initiation factor-4E binding to 5′-capped oligoribonucleotides by modified anti-sense oligonucleotides by Baker (1992)10.1126/science.8351515
/ Science / Antisense oligonucleotides as therapeutic agents—Is the bullet really magical by Stein (1993){'key': '10.1038/ki.1995.205_bb0035', 'series-title': 'Int Union of Biochemistry Conf on Nucleic Acid Therapeutics', 'first-page': '71', 'article-title': 'Synthesis and biophysical studies of 2′-d-ribo-f modified oligonucleotides', 'author': 'Kawasaki', 'year': '1991'}
/ Int Union of Biochemistry Conf on Nucleic Acid Therapeutics / Synthesis and biophysical studies of 2′-d-ribo-f modified oligonucleotides by Kawasaki (1991){'key': '10.1038/ki.1995.205_bb0040', 'first-page': '1157', 'article-title': '[Mechanism for suppression mRNA translation with antisense oligonucleotides]', 'volume': '24', 'author': 'Vlasov', 'year': '1990', 'journal-title': 'Mol Biol (Moskow)'}
/ Mol Biol (Moskow) / [Mechanism for suppression mRNA translation with antisense oligonucleotides] by Vlasov (1990)10.1128/jvi.67.11.6882-6888.1993
/ J Virol / Inhibition of Rev activity and human immunodeficiency virus type 1 replication by antisense oligodeoxynucleotide phosphorothioate analogs directed against the Revresponsive element by Li (1993)10.1073/pnas.85.15.5507
/ Proc Natl Acad Sci USA / Inhibition of human immunodeficiency virus replication by anti-sense oligodeoxynucleotides by Goodchild (1988)10.1089/ard.1992.2.261
/ Antisense Res Dev / GEM 91—An antisense oligonucleotide phosphorothioate as a therapeutic agent for AIDS by Agrawal (1992)10.1126/science.2897717
/ Science / Inhibition of cellular proliferation by antisense oligodeoxynucleotides to PCNA cyclin by Jaskulski (1988)10.1126/science.2218499
/ Science / Extension of the life-span of human endothelial cells by an interleukin-1 alpha antisense oligomer by Maier (1990)10.1093/nar/19.12.3359
/ Nucl Acids Res / Inhibition of HIV-LTR gene expression by oligonucleotides targeted to the TAR element by Vickers (1991)10.1073/pnas.90.3.1023
/ Proc Natl Acad Sci USA / The c-rel protooncogene product represses NF-kappa B p65-mediated transcriptional activation of the long terminal repeat of type 1 human immunodeficiency virus by Doerre (1993)10.1128/AAC.37.2.171
/ Antimicrob Agents Chemother / In vitro evaluation of phosphorothioate oligonucleotides targeted to the E2 mRNA of papillomavirus: Potential treatment for genital warts by Cowsert (1993)10.1126/science.2237444
/ Science / Regulation of gene expression with double-stranded phosphorothioate oligonucleotides by Bielinska (1990)10.1073/pnas.88.4.1516
/ Proc Natl Acad Sci USA / Epithelial-mesenchymal transformation of embryonic cardiac endothelial cells is inhibited by a modified antisense oligodeoxynucleotide to transforming growth factor beta 3 by Potts (1991)10.1073/pnas.89.24.11823
/ Proc Natl Acad Sci USA / In vivo treatment of human leukemia in a scid mouse model with c-myb antisense oligodeoxynucleotides by Ratakczal (1992)10.1126/science.1299224
/ Science / Ablation of transplanted HTLV-I Tax-transformed tumors in mice by antisense inhibition of NF-kappa B by Kitajima (1992){'key': '10.1038/ki.1995.205_bb0105', 'first-page': '849', 'article-title': 'Antisense oligonucleotides as potential antiviral and anticancer agents', 'volume': '76', 'author': 'Le Doan', 'year': '1989', 'journal-title': 'Bull Cancer (Paris)'}
/ Bull Cancer (Paris) / Antisense oligonucleotides as potential antiviral and anticancer agents by Le Doan (1989)10.1038/bjc.1991.3
/ Br J Cancer / Synthetic oligonucleotides as therapeutic agents by Tidd (1991)10.1089/ard.1992.2.109
/ Antisense Res Dev / Systemic human antisense therapy begins by Bayever (1992)10.1016/0305-7372(93)90033-N
/ Cancer Treat Rev / Prospects for gene-directed therapy with antisense oligodeoxynucleotides by Calabretta (1993){'key': '10.1038/ki.1995.205_bb0125', 'first-page': '539', 'article-title': 'Phosphorothioate oligonucleotides: Chemistry, purification, analysis, scale-up and future directions', 'volume': '6', 'author': 'Zon', 'year': '1991', 'journal-title': 'Anticancer Drug Des'}
/ Anticancer Drug Des / Phosphorothioate oligonucleotides: Chemistry, purification, analysis, scale-up and future directions by Zon (1991)10.1021/bi00081a031
/ Biochemistry / Oligodeoxynucleotides containing 2′-O-modified adenosine: Synthesis and effects on stability of DNA:RNA duplexes by Lesnik (1993)10.1093/nar/19.11.2979
/ Nucl Acids Res / Duplex stabilities of phosphorothioate, methylphosphonate, and RNA analogs of two DNA 14-mers by Kibler-Herzog (1991)10.1093/nar/21.11.2729
/ Nucl Acids Res / Self-stabilized antisense oligodeoxynucleotide phosphorothioates: Properties and anti-HIV activity by Tang (1993)10.1093/jnci/81.20.1539
/ J Natl Cancer Inst / Oligodeoxynucleotides as anti-sense inhibitors of gene expression: Therapeutic implications by Rothenberg (1989)10.1089/ard.1993.3.53
/ Antisense Res Dev / Comparison of cellular binding and uptake of antisense phosphodiester, phosphorothioate, and mixed phosphorothioate and methylphosphonate oligonucleotides by Zhao (1993)10.1089/ard.1992.2.17
/ Antisense Res Dev / Analysis of oligonucleotide binding, internalization, and intracellular trafficking utilizing a novel radiolabeled crosslinker by Geselowitz (1992)10.1073/pnas.86.10.3474
/ Proc Natl Acad Sci USA / Characterization of oligonucleotide transport into living cells by Loke (1989){'key': '10.1038/ki.1995.205_bb0165', 'series-title': 'Nucl Acids Symp Ser', 'first-page': '311', 'article-title': 'Interaction of oligonucleotides with cellular receptors', 'author': 'Yakubov', 'year': '1991'}
/ Nucl Acids Symp Ser / Interaction of oligonucleotides with cellular receptors by Yakubov (1991){'key': '10.1038/ki.1995.205_bb0170', 'first-page': '962', 'article-title': '[Affinity modification of proteins, binding nucleic acids in mammalian cells, by alkylating derivatives of oligonucleotides]', 'volume': '58', 'author': 'Vlasov', 'year': '1993', 'journal-title': 'Biokhimiia'}
/ Biokhimiia / [Affinity modification of proteins, binding nucleic acids in mammalian cells, by alkylating derivatives of oligonucleotides] by Vlasov (1993){'key': '10.1038/ki.1995.205_bb0175', 'first-page': '1091', 'article-title': 'Rapid nuclear accumulation of injected oligodeoxyribonucleotides', 'volume': '2', 'author': 'Chin', 'year': '1990', 'journal-title': 'New Biol'}
/ New Biol / Rapid nuclear accumulation of injected oligodeoxyribonucleotides by Chin (1990)10.1073/pnas.88.7.2702
/ Proc Natl Acad Sci USA / Intracellular distribution of microinjected antisense oligonucleotides by Leonetti (1991){'key': '10.1038/ki.1995.205_bb0185', 'series-title': 'Nucl Acids Symp Ser', 'first-page': '147', 'article-title': 'Nuclear location of synthetic oligonucleotides microinjected somatic cells: Its implication in an antisense strategy', 'author': 'Mechti', 'year': '1991'}
/ Nucl Acids Symp Ser / Nuclear location of synthetic oligonucleotides microinjected somatic cells: Its implication in an antisense strategy by Mechti (1991)10.1111/1523-1747.ep12371683
/ J Invest Dermatol / Characteristics of oligonucleotide uptake in human keratinocyte cultures by Noonberg (1993)10.1073/pnas.86.17.6454
/ Proc Natl Acad Sci USA / Mechanism of oligonucleotide uptake by cells: Involvement of specific receptors by Yakubov (1989)10.1111/1523-1747.ep12875170
/ J Invest Dermatol / Identification of a cell-surface DNA receptor and its association with systemic lupus erythematosus by Hefeneider (1990)10.1177/096120339200100308
/ Lupus / DNA binding to mouse cells is mediated by cell-surface molecules: The role of these DNA-binding molecules as target antigens in murine lupus by Hefeneider (1992)10.1073/pnas.88.17.7595
/ Proc Natl Acad Sci USA / Pharmacokinetics, biodistribution, and stability of oligodeoxynucleotide phosphorothioates in mice by Agrawal (1991)10.1002/bdd.2510130308
/ Biopharm Drug Dispos / Organ distribution and stability of phosphorothioated oligodeoxyribonucleotides in mice by Goodarzi (1992){'key': '10.1038/ki.1995.205_bb0220', 'first-page': '1181', 'article-title': 'Pharmacokinetics of a 14C-labeled phosphorothioate oligonucleotide, ISIS 2105, after intradermal administration to rats', 'volume': '267', 'author': 'Cossum', 'year': '1993', 'journal-title': 'J Pharmacol Exp Ther'}
/ J Pharmacol Exp Ther / Pharmacokinetics of a 14C-labeled phosphorothioate oligonucleotide, ISIS 2105, after intradermal administration to rats by Cossum (1993)10.1097/00007890-199311000-00021
/ Transplantation / Alterations in renal interleukin-1 production during kidney transplant rejection in the rat. The effects of high-dose methylprednisolone by Mannon (1993)10.1016/0003-2697(90)90521-A
/ Anal Biochem / Preparation of 35S-labeled polyphosphorothioate oligodeoxyribonucleotides by use of hydrogen phosphonate chemistry by Stein (1990)10.3109/09687687809063848
/ Membr Biochem / Properties of brush border vesicles isolated from rat kidney cortex by calcium precipitation by Evers (1978){'key': '10.1038/ki.1995.205_bb0240', 'first-page': '1497', 'article-title': 'A novel sequence in the type IV collagen promoter binds nuclear proteins from Engelbreth-Holm-Swarm tumor', 'volume': '7', 'author': 'Bruggeman', 'year': '1992', 'journal-title': 'Oncogene'}
/ Oncogene / A novel sequence in the type IV collagen promoter binds nuclear proteins from Engelbreth-Holm-Swarm tumor by Bruggeman (1992)10.1089/ard.1991.1.153
/ Antisense Res Dev / The clearance and degradation of oligodeoxynucleotides following intravenous injection into rabbits by Goodchild (1991)10.1021/bi00843a023
/ Biochemistry / Kinetics of the photochemical addition of 35S cysteine to polynucleotides and nucleic acids by Smith (1968)10.1159/000207812
/ Acta Haematol / Binding of deoxyribonucleic acid to the surface of human platelets by Clejan (1977)10.1172/JCI112226
/ J Clin Invest / DNA binding to human leukocytes. Evidence for a receptor-mediated association, internalization, and degradation of DNA by Bennett (1985)10.1016/S0378-4347(00)82193-3
/ J Chromatogr / High performance liquid chromatographic analysis of phosphorothioate analogues of oligodeoxynucleotides in biological fluids by Bigelow (1990)10.1016/S0021-9258(18)35691-6
/ J Biol Chem / Human T-cell leukemia virus type I tax transformation is associated with increased uptake of oligodeoxynucleotides in vitro and in vivo by Kitajima (1992)10.1089/ard.1992.2.223
/ Antisense Res Dev / Binding of antisense phosphorothioate oligonucleotides to murine lymphocytes is lineage specific and inducible by Iversen (1992)10.1073/pnas.80.8.2196
/ Proc Natl Acad Sci USA / Cloning and sequence analysis of cDNA for rat angiotensinogen by Ohkubo (1990)10.1016/0002-9343(91)80081-V
/ Am J Med / Systemic treatment of AIDS-related Kaposi's sarcoma: Results of a randomized trial by Gill (1991)10.1016/0006-291X(91)92086-Y
/ Biochem Biophys Res Commun / Binding of oligonucleotides to cell membranes at acidic pH by Goodarzi (1991)- U.M. Sarmiento J.R. Perez J.M. Becker R. Narayanan In vivo toxicological effects of rel A antisense phosphorothioates in CD-1 mice Antisense Res Dev (in press)
Dates
Type | When |
---|---|
Created | 18 years, 3 months ago (May 21, 2007, 1:49 p.m.) |
Deposited | 3 years, 9 months ago (Oct. 29, 2021, 6:59 p.m.) |
Indexed | 3 weeks, 4 days ago (Aug. 2, 2025, 12:41 a.m.) |
Issued | 30 years, 3 months ago (May 1, 1995) |
Published | 30 years, 3 months ago (May 1, 1995) |
Published Print | 30 years, 3 months ago (May 1, 1995) |
@article{Rappaport_1995, title={Transport of phosphorothioate oligonucleotides in kidney: Implications for molecular therapy}, volume={47}, ISSN={0085-2538}, url={http://dx.doi.org/10.1038/ki.1995.205}, DOI={10.1038/ki.1995.205}, number={5}, journal={Kidney International}, publisher={Elsevier BV}, author={Rappaport, Jay and Hanss, Basil and Kopp, Jeffrey B. and Copeland, Terry D. and Bruggeman, Leslie A. and Coffman, Thomas M. and Klotman, Paul E.}, year={1995}, month=may, pages={1462–1469} }